Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699527 · ClinicalTrials.gov registry record
Medical Cannabis Registry and Pharmacology
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 119
- Enrollment target
NCT03699527 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 119 participants.
The verdict
NCT03699527 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
The overall goals of this research is to describe the 1) natural history of current use and disposition of medical cannabis products including Cannabidiol (CBD) products, being administered to children as standard of care for the treatment of Autism Spectrum Disorder (ASD), 2) understand the pharmacokinetic and pharmacodynamics of medical cannabis products and 3) provide educational feedback on what is learned to families and care providers to provide evidenced based dosing guidance for these products to the pediatric community.
Interventions
- BEHAVIORAL Multiple questionnaires administered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2018-07-15 |
| Est. Completion | 2020-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699527
The ClinicalTrials.gov registry entry for NCT03699527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multiple questionnaires administered is the first listed.
NCT03699527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699527 about?
NCT03699527 is a clinical study titled "Medical Cannabis Registry and Pharmacology". The overall goals of this research is to describe the 1) natural history of current use and disposition of medical cannabis products including Cannabidiol (CBD) products, being administered to children as standard of care for the treatment of Autism Spectrum Disorder (ASD), 2) understand the pharmac...
What is the current status of trial NCT03699527?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2018-07-15. Estimated completion is 2020-01-15.
What interventions are being tested in trial NCT03699527?
The interventions under investigation include: Multiple questionnaires administered (BEHAVIORAL).
Who is sponsoring clinical trial NCT03699527?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.